Finance

Lists
Outlook: 63.2% bullish·0.0% bearish
Go to analysis
RVMD:NASDAQ
Revolution Medicines Inc
၁၉၀.၂၆ US$
+၁.၁၄%
(+၂.၁၄) 1D
အောက် ၉, GMT-၄ ၁၄:၀၃:၁၅  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RVMD...
Open
၁၈၆.၀၁ US$
High
၁၉၃.၅၀ US$
Low
၁၈၄.၃၇ US$
Mkt. cap
ဋေ ၄.၀၈ ထ
Avg. vol.
၂.၀၉ သန်း
Volume
၁.၁၈ သန်း
52-wk high
၂၂၄.၃၁ US$
52-wk low
၄၇.၃၂ US$
EPS
-၈.၈၃ US$
Beta
၁.၄၀
Shares outstanding
၂၁.၄၃ ကုဋေ
No. of employees
၈၈၃
Open
၁၈၆.၀၁ US$
High
၁၉၃.၅၀ US$
Low
၁၈၄.၃၇ US$
Mkt. cap
ဋေ ၄.၀၈ ထ
Avg. vol.
၂.၀၉ သန်း
Volume
၁.၁၈ သန်း
52-wk high
၂၂၄.၃၁ US$
52-wk low
၄၇.၃၂ US$
EPS
-၈.၈၃ US$
Beta
၁.၄၀
Shares outstanding
၂၁.၄၃ ကုဋေ
No. of employees
၈၈၃
News stories
From web sources and news partners
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၂၁ နာရီ
TD Cowen Maintains Buy on Revolution Medicines (RVMD) Despite Re
Stocks Down Under
Stocks Down Under
·
ပြီးခဲ့သည့် ၂၃ နာရီ
Revolution Medicines (NDQ:RVMD): Its Already The Most Advanced RAS Company And There's More To Come
Benzinga
Benzinga
·
ပြီးခဲ့သည့် ၁ ရက်
Stock Market Today: S&P 500 Slips as Oil Spikes 5%, 10-Year Yields Near 5.35%
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ ရက်
Will Phase 3 Trial Start Change Revolution Medicines (RVMD) Narrative
About Revolution Medicines Inc
CEO-
Employees၈၈၃
Founded၂၀၁၄
HeadquartersRedwood City, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiterevmed.com
Analyst ratings
Based on 23 analysts giving stock ratings to RVMD in the past 3 months
Strong buy
Buy
22
Hold
1
Sell
0
12-month forecast
Based on 23 Wall Street analysts offering 12 month price targets for RVMD in the last 3 months.
Highest
Current ၁၉၀.၂၆ US$
၃၂၀.၀၀ US$ (+၆၈.၁၉%)
Average
၂၅၈.၆၂ US$ (+၃၅.၉၃%)
Lowest
၁၇၉.၀၀ US$ (-၅.၉၂%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Schmidt
Guggenheim
Buy
Maintained
၂၇၅.၀၀ US$
+၄၄.၅%
10/08/2026
Alec Stranahan
Bank of America Securities
Buy
Maintained
၂၆၄.၀၀ US$
+၃၈.၈%
10/09/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
10/08/2026
Laura Prendergast
Stifel Nicolaus
Buy
Maintained
-
-
10/08/2026
Leonid Timashev
RBC Capital
Buy
Maintained
၂၅၉.၀၀ US$
+၃၆.၁%
10/08/2026
Gregory Renza
Truist Financial
Buy
Maintained
၂၄၀.၀၀ US$
+၂၆.၁%
10/07/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
၃၁၅.၀၀ US$
+၆၅.၆%
10/05/2026
Leah R. Cann
Brookline Capital Markets
Buy
Initiated
၃၁၈.၀၀ US$
+၆၇.၁%
09/28/2026
Jeffrey Walch
Bernstein
Hold
Maintained
၁၇၉.၀၀ US$
-၅.၉%
09/25/2026
Andrea Newkirk
Goldman Sachs
Buy
Initiated
၂၆၇.၀၀ US$
+၄၀.၃%
09/24/2026
Sean Laaman
Morgan Stanley
Buy
Initiated
၂၅၅.၀၀ US$
+၃၄%
09/10/2026
Faisal Khurshid
Jefferies
Buy
Maintained
၂၇၀.၀၀ US$
+၄၁.၉%
09/03/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
၂၄၆.၀၀ US$
+၂၉.၃%
09/01/2026
Ami Fadia
Needham
Buy
Reiterated
၂၇၅.၀၀ US$
+၄၄.၅%
08/31/2026
Michael Yee
UBS
Buy
Maintained
၂၆၅.၀၀ US$
+၃၉.၃%
08/28/2026
Sean McCutcheon
Raymond James
Buy
Maintained
၂၄၈.၀၀ US$
+၃၀.၃%
08/27/2026
Jay Olson
Oppenheimer
Buy
Maintained
၂၆၀.၀၀ US$
+၃၆.၇%
08/27/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
၃၂၀.၀၀ US$
+၆၈.၂%
08/27/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Reiterated
၂၄၀.၀၀ US$
+၂၆.၁%
08/27/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
၂၈၀.၀၀ US$
+၄၇.၂%
08/27/2026
Robert Driscoll
Wedbush
Buy
Maintained
၂၂၅.၀၀ US$
+၁၈.၃%
08/27/2026
Kalpit Patel
Wolfe Research
Buy
Maintained
၂၂၀.၀၀ US$
+၁၅.၆%
08/10/2026
Marc Frahm
TD Cowen
Buy
Reiterated
-
-
08/10/2026
Joseph Catanzaro
Mizuho Securities
Buy
Reiterated
၂၁၅.၀၀ US$
+၁၃%
08/05/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
၂၁၀.၀၀ US$
+၁၀.၄%
08/06/2026
Unknown Analyst
Bernstein
Hold
Maintained
၁၅၁.၀၀ US$
-၂၀.၆%
06/07/2026
Michael Morris
Guggenheim
Buy
Maintained
၁၇၅.၀၀ US$
-၈%
04/22/2026
Jonathan Chang
Leerink Partners
Buy
Reiterated
၁၄၇.၀၀ US$
-၂၂.၇%
04/13/2026
Asthika Goonewardene
Truist Financial
Buy
Maintained
-
-
03/09/2026
Last report
၂၀၂၆ ဩ ၅
Fiscal period
Q2 2026
-၃.၀၆ US$ / -၂.၀၆ US$
-၄၈.၇၇%miss
Revenue / Est. (USD)
- / ၁.၆၄ ကုဋေ
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
၂၆.၂၅ ကုဋေ
၂၉.၄၉ ကုဋေ
၃၄.၄၀ ကုဋေ
၃၉.၄၉ ကုဋေ
Cost of revenue
၂၆.၂၅ ကုဋေ
၂၉.၄၉ ကုဋေ
၃၄.၄၀ ကုဋေ
၃၉.၄၉ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၅.၂၈ ကုဋေ
၆.၆၇ ကုဋေ
၁၀.၁၃ ကုဋေ
၁၁.၀၂ ကုဋေ
Operating expense
၅.၂၈ ကုဋေ
၆.၆၇ ကုဋေ
၁၀.၁၃ ကုဋေ
၁၁.၀၂ ကုဋေ
Total operating expenses
၃၁.၅၃ ကုဋေ
၃၆.၁၆ ကုဋေ
၄၄.၅၂ ကုဋေ
၅၀.၅၁ ကုဋေ
Operating income
-၃၁.၅၃ ကုဋေ
-၃၆.၁၆ ကုဋေ
-၄၄.၅၂ ကုဋေ
-၅၀.၅၁ ကုဋေ
Other non operating income
-၅.၉၂ သိန်း
-၁.၂၆ ကုဋေ
-၁.၅၉ ကုဋေ
-၁၅.၁၀ ကုဋေ
EBT including unusual items
-၃၀.၅၂ ကုဋေ
-၃၆.၄၉ ကုဋေ
-၄၅.၃၈ ကုဋေ
-၆၄.၄၄ ကုဋေ
EBT excluding unusual items
-၃၀.၅၂ ကုဋေ
-၃၆.၄၉ ကုဋေ
-၄၅.၃၈ ကုဋေ
-၆၄.၄၄ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၃၀.၅၂ ကုဋေ
-၃၆.၄၉ ကုဋေ
-၄၅.၃၈ ကုဋေ
-၆၄.၄၄ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၁.၆၁
-၁.၈၆
-၂.၂၉
-၃.၀၆
Interest and investment income
၂.၂၁ ကုဋေ
၂.၁၃ ကုဋေ
၁.၉၅ ကုဋေ
၃.၅၆ ကုဋေ
Interest expense
-၁.၁၄ ကုဋေ
-၁.၁၉ ကုဋေ
-၁.၂၂ ကုဋေ
-၂.၃၈ ကုဋေ
Net interest expenses
၁.၀၇ ကုဋေ
၉.၃၆ သန်း
၇.၃၁ သန်း
၁.၁၈ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၃၁.၃၂ ကုဋေ
-၃၅.၉၄ ကုဋေ
-၄၄.၂၉ ကုဋေ
-၅၀.၂၇ ကုဋေ
Gain or loss from assets sale
၃.၂၀ သောင်း
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ